r21/matrix-m adjuvant malaria vaccine
r21/matrix-m adjuvant malaria vaccine: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| NOVAVAX INC (NVAX) | Approved |
Get deeper analysis on r21/matrix-m adjuvant malaria vaccine
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis